AC Immune ACIU
NASDAQ ACIU
$2.72 -0.09 (-3.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

AC Immune (ACIU) Interest & Investment Income (2014 - 2026)

Updated

AC Immune's Interest & Investment Income came in at -$894,524 for the quarter ended Jun 30, 2026, compared with $553,214 a year earlier.

Analysis

AC Immune (ACIU) Interest & Investment Income (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, AC Immune reported Interest & Investment Income of -$1.03 million; for the year ended Dec 31, 2025, it was $2.25 million, down 38.1% from the prior year.

  • Interest & Investment Income carries a five-year compound annual growth rate of 41.2% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Interest & Investment Income was $3.63 million in the year ended Dec 31, 2024 (+212.5%), $1.16 million in the year ended Dec 31, 2023, -$585,991 in the year ended Dec 31, 2022 and -$7.41 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 represents the lowest quarterly Interest & Investment Income since the quarter ended Dec 31, 2024.
  • Year-over-year, Interest & Investment Income increased in two of the last five quarters, with growth averaging 18.0%.
  • The fastest year-over-year change in Interest & Investment Income over five years came in the quarter ended Sep 30, 2024 (growth of 235.9%), and the weakest in the quarter ended Sep 30, 2022 (a decline of 99.8%).
  • Business Quant data shows ACIU's Interest & Investment Income at $291,157 (quarter ended Mar 31, 2026), -$887,079 (quarter ended Dec 31, 2025) and $457,540 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 AC Immune 276.74 Mn 276.74 Mn - -894,524.05
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -894,524.05
Mar 31, 2026 291,157.07
Dec 31, 2025 -887,079.38
Sep 30, 2025 457,540.08
Jun 30, 2025 553,213.72
Mar 31, 2025 764,116.12
Dec 31, 2024 -2.57 Mn
Sep 30, 2024 1.08 Mn
Jun 30, 2024 817,181.39
Mar 31, 2024 720,634.18
Dec 31, 2023 190,522.91
Sep 30, 2023 322,663.48
Jun 30, 2023 288,053.47
Mar 31, 2023 225,962.98
Dec 31, 2022 -591,672.49
Sep 30, 2022 11,390.02
Jun 30, 2022 -435,044.77
Mar 31, 2022 -193,822.70
Dec 31, 2021 -12.14 Mn
Sep 30, 2021 4.82 Mn
API Access

AC Immune Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ACIU&period=max&api_key=YOUR_API_KEY